scholarly article | Q13442814 |
P2093 | author name string | Ramesh K Ganju | |
Lianbo Yu | |||
Mohd W Nasser | |||
Yadwinder S Deol | |||
Xianghong Zou | |||
P2860 | cites work | Psoriasin (S100A7) expression and invasive breast cancer | Q22010926 |
Psoriasin expression in mammary epithelial cells in vitro and in vivo | Q24292122 | ||
A putative role for psoriasin in breast tumor progression | Q24298889 | ||
Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly | Q24312910 | ||
Gene from a psoriasis susceptibility locus primes the skin for inflammation | Q24314913 | ||
S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast | Q24805971 | ||
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells | Q27860717 | ||
Psoriasin interacts with Jab1 and influences breast cancer progression | Q28191754 | ||
Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway | Q28217024 | ||
Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway | Q28505373 | ||
WNT and beta-catenin signalling: diseases and therapies | Q29616159 | ||
S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells | Q33305131 | ||
S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation | Q33322536 | ||
Control of beta-catenin signaling in tumor development. | Q33981342 | ||
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer | Q34026054 | ||
Actin dynamics and cell-cell adhesion in epithelia | Q34132779 | ||
Molecular architecture of adherens junctions | Q34360617 | ||
Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis | Q34513406 | ||
Beta-catenin and Tcfs in mammary development and cancer | Q34543461 | ||
Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis | Q34603580 | ||
The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion. | Q34688333 | ||
Wnt signaling in human cancer | Q35076037 | ||
Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22. | Q36685203 | ||
Slit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells | Q36897655 | ||
The role of LEF/TCF factors in neoplastic transformation | Q37090101 | ||
E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer | Q37372547 | ||
The links between transcription, beta-catenin/JNK signaling, and carcinogenesis | Q37578108 | ||
Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cells | Q39650570 | ||
A simplified method for quantifying cell migration/wound healing in 96-well plates | Q39731401 | ||
S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer. | Q39747948 | ||
Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes | Q40018737 | ||
Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. | Q40020050 | ||
The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer | Q40402282 | ||
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors | Q40949632 | ||
Human epidermal differentiation complex in a single 2.5 Mbp long continuum of overlapping DNA cloned in bacteria integrating physical and transcript maps | Q42604357 | ||
Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients. | Q43199946 | ||
Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer | Q44509716 | ||
Stimulation of MCF-7 tumor progression in athymic nude mice by 17beta-estradiol induces WISP-2/CCN5 expression in xenografts: a novel signaling molecule in hormonal carcinogenesis. | Q45261595 | ||
Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation | Q60240274 | ||
Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ("epidermal differentiation complex") on human chromosome 1q21 | Q71049670 | ||
Psoriasin: a novel chemotactic protein | Q71384309 | ||
Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma | Q71614084 | ||
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining | Q72313935 | ||
Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21 | Q83237938 | ||
P433 | issue | 52 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | estrogen-receptor positive breast cancer | Q18553636 |
P1104 | number of pages | 10 | |
P304 | page(s) | 44845-44854 | |
P577 | publication date | 2011-10-20 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells | |
P478 | volume | 286 |
Q40133231 | Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway. |
Q33804642 | Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling |
Q37554595 | Distinct prognostic values of S100 mRNA expression in breast cancer |
Q34419405 | FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway |
Q37001259 | Functions of S100 proteins. |
Q38703693 | Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma. |
Q38118075 | Joining S100 proteins and migration: for better or for worse, in sickness and in health. |
Q38105784 | Opposing functions of psoriasin (S100A7) and koebnerisin (S100A15) in epithelial carcinogenesis. |
Q64086561 | Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance |
Q37650123 | S100 protein family in human cancer |
Q35206368 | S100 proteins in cancer |
Q92964700 | S100 proteins: An emerging cynosure in pregnancy & adverse reproductive outcome |
Q38913035 | S100A7 acts as a dual regulator in promoting proliferation and suppressing squamous differentiation through GATA-3/caspase-14 pathway in A431 cells |
Q51371324 | S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. |
Q33648719 | S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition |
Q34700918 | S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway |
Q21195847 | The secreted protein S100A7 (psoriasin) is induced by telomere dysfunction in human keratinocytes independently of a DNA damage response and cell cycle regulators |
Q98164431 | Unveiling functional heterogeneity in breast cancer multicellular tumor spheroids through single-cell RNA-seq |
Q35041332 | miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer |